Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: A model of surrogate human hepatitis B virus infectivity

Transfusion

Volumn 36, Issue 5, 1996, Pages 406-418

  Eble, B E ^a   Corash, L ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Steritech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN; THROMBOCYTE CONCENTRATE; VIRUS RNA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCK; GENE AMPLIFICATION; HEPATITIS B VIRUS; NONHUMAN; PHOTOCHEMISTRY; QUANTITATIVE ASSAY; THROMBOCYTE TRANSFUSION; ULTRAVIOLET RADIATION; VIREMIA; VIRUS INACTIVATION; VIRUS INFECTIVITY;

EID: 0029920256     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36596282583.x     Document Type: Article

References (78)

1. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Morb Mortal Wkly Rep 1991;40(RR-4):1-17.
2. Dodd RY. The risk of transfusion-transmitted infection (editorial). N Engl J Med 1992;327:419-21.
3. Barbara JA. Hepatitis B: old virus, new problems? Vox Sang 1994;67(Suppl 3):239-42.
4. Brechot C, Kremsdorf D, Paterlini P, Thiers V. Hepatitis B virus DNA in HBsAg-negative patients. Molecular characterization and clinical implications. J Hepatol 1991;13(Suppl 4):S49-55.
5. Kojima M, Shimizu M, Tsuchimochi T, et al. Posttransfusion fulminant hepatitis B associated with precore-defective HBV mutants. Vox Sang 1991;60:34-9.
6. Preisler-Adams S, Schlayer HJ, Peters T, et al. Sequence analysis of hepatitis B virus DNA in immunologically negative infection. Arch Virol 1993;133:385-96.
7. Uchida T, Shimojima M, Gotoh K, et al. Silent hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol 1994;38:281-5.
8. Wands JR, Liang TJ, Blum HE, Shafritz DA. Molecular pathogenesis of liver disease during persistent hepatitis B virus infection. Semin Liver Dis 1992;12:252-64.
9. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988;2:1273-6.
10. Corash L, Lin L, Wiesehahn G. Use of 8-methoxypsoralen and long wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood Cells 1992;18:57-74.
11. Lin L, Wiesehahn GP, Morel PA, Corash L. Use of 8-methoxypsoralen and long-wavelength ultraviolet radiation for decontamination of platelet concentrates. Blood 1989;74:517-25.
12. Lin L, Londe H, Hanson CV, et al. Psoralen photochemical inactivation of cell-free HIV-1 in platelet concentrates is correlated with the inhibition of reverse transcription using an RT/PCR assay (abstract). Blood 1992;80(Suppl 1):223a.
13. Lin L, Londe H, Hanson CV, et al. Photochemical inactivation of cell-associated human immunodeficiency virus in platelet concentrates. Blood 1993;82:292-7.
14. Lin L, Londe H, Janda JM, et al. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994;83:2698-706.
15. Alter HJ, Creagan RP, Morel PA, et al. Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus. Lancet 1988;2:1446-50.
16. Ganem D, Varmus HE. The molecular biology of the hepatitis B viruses. Annu Rev Biochem 1987;56:651-93.
17. Long Z, Sun CS, White EM, et al. Hepatitis B viral clearance studies using duck virus model. Dev Biol Stand 1993;81:163-8.
18. Prince DL, Prince HN, Thraenhart O, et al. Methodological approaches to disinfection of human hepatitis B virus. J Clin Microbiol 1993;31:3296-304.
19. Tsiquaye KN, Barnard J. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus. J Antimicrob Chemother 1993;32:313-23.
20. Pugh JC, Summers JW. Infection and uptake of duck hepatitis B virus by duck hepatocytes maintained in the presence of dimethyl sulfoxide. Virology 1989;172:564-72.
21. Tuttleman JS, Pugh JC, Summers JW. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J Virol 1986;58:17-25.
22. Condreay LD, Aldrich CE, Coates L, et al. Efficient duck hepatitis B virus production by an avian liver tumor cell line. J Virol 1990;64:3249-58.
23. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A 1984;81:1991-5.
24. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
25. Murray SM, Freiman JS, Vickery K, et al. Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity. Epidemiol Infect 1991;106:435-43.
26. Berry MN, Edwards AM, Barritt GJ, ed. Isolated hepatocytes: preparation, properties and applications. In: Burdon RH, van Knippenberg PH, eds. Laboratory techniques in biochemistry and molecular biology, vol 21. Amsterdam: Elsevier, 1991:52.
27. Kwok S. Procedures to minimize PCR-product carry-over. In: Innis MA, Gelfand DH, Sninsky JJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:142-5.
28. Prince AM, Andrus L. PCR: how to kill unwanted DNA. Biotechniques 1992;12:358-60.
29. Kellogg DE, Kwok S. Detection of human immunodeficiency virus. In: Innis MA, Gelfand DH, Sninsky JJ, eds. PCR protocols: a guide to methods and applications. San Diego: Academic Press, 1990:337-47.
30. Lin L, Cook D, Londe H, et al. Use of variable length amplicons to determine the efficiency of viral inactivation by psoralen mediated photochemistry (abstract). Blood 1993;82(Suppl 1):401a.
31. Sprengel R, Kuhn C, Will H, Schaller H. Comparative sequence analysis of duck and human hepatitis B virus genomes. J Med Virol 1985;15:323-33.
32. Mason WS, Halpern MS, England JM, et al. Experimental transmission of duck hepatitis B virus. Virology 1983;131:375-84.
33. Marion PL, Trepo C, Matsubara K, Price PM. Experimental models in hepadnavirus research: report of a workshop. In: Hollinger FB, Lemon SM, Margolis H, eds. Viral hepatitis and liver disease: proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: contemporary issues and future prospects. Baltimore: Williams & Wilkins, 1991:866-74.
34. Offensperger WB, Offensperger S, Walter E, et al. Sulfated polyanions do not inhibit duck hepatitis B virus infection. Antimicrob Agents Chemother 1991;35:2431-3.
35. Morel P, Lin L, Wiesehahn G, Corash L. Photochemical inactivation of viruses and bacteriophage in plasma and plasma fractions. Blood Cells 1992;18:27-42.
36. Harrison TJ. Hepatitis B virus DNA in peripheral blood leukocytes: a brief review. J Med Virol 1990;31:33-5.
37. Rigg RJ, Schaller H. Duck hepatitis B virus infection of hepatocytes is not dependent on low pH. J Virol 1992;66:2829-36.
38. Cheung RC, Trujillo DE, Robinson WS, et al. Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks. Virology 1990;176:546-52.
39. Marion PL, Cullen JM, Azcarraga RR, et al. Experimental transmission of duck hepatitis B virus to Pekin ducks and to domestic geese. Hepatology 1987;7:724-31.
40. Munshi A, Mehrotra R, Ramesh R, Panda SK. Evaluation of anti-hepadnavirus activity of Phyllanthus amarus and Phyllanthus maderaspatensis in duck hepatitis B virus carrier Pekin ducks. J Med Virol 1993;41:275-81.
41. Omata M, Yokosuka O, Imazeki F, et al. Transmission of duck hepatitis B virus from Chinese carrier ducks to Japanese ducklings: a study of viral DNA in serum and tissue. Hepatology 1984;4:603-7.
42. Jilbert AR, Wu TT, England JM, et al. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 1992;66:1377-88.
43. Freiman JS, Jilbert AR, Dixon RJ, et al. Experimental duck hepatitis B virus infection: pathology and evolution of hepatic and extrahepatic infection. Hepatology 1988;8:507-13.
44. Tagawa M, Omata M, Yokosuka O, et al. Early events in duck hepatitis B virus infection. Sequential appearance of viral deoxyribonucleic acid in the liver, pancreas, kidney, and spleen. Gastroenterology 1985;89:1224-9.
45. Ogata N, Miller RH, Ishak KG, Purcell RH. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees. Virology 1993;194:263-76.
46. Chuang WL, Omata M, Ehata T, et al. Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklings. Hepatology 1994;19:569-76.
47. Corash L, Lin C, Reames A, Lin L. Post-transfusion in vivo platelet survival following photochemical treatment: a murine model (abstract). Blood 1993;82(Suppl 1):401a.
48. Dodd RY, Moroff G, Wagner S, et al. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods. Transfusion 1991;31:483-90.
49. Wagner SJ, Bardossy L, Moroff G, et al. Assessment of the hemostatic effectiveness of human platelets treated with aminomethyltrimethyl psoralen and UV A light using a rabbit ear bleeding time technique. Blood 1993;82:3489-92.
50. Eble B, Villena F, Chen C, Corash L. Photochemical inactivation of duck hepatitis B virus (DHBV) in human platelet concentrates: correlation of in vitro and in vivo effects (abstract). Blood 1993;82(Suppl 1):205a.
51. Tabor E, Purcell RH, London WT, Gerety RJ. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis 1983;147:531-4.
52. Suomela H. Inactivation of viruses in blood and plasma products. Transfus Med Rev 1993;7:42-57.
53. Wagner SJ, Friedman LI, Dodd RY. Approaches to the reduction of viral infectivity in cellular blood components and single donor plasma. Transfus Med Rev 1991;5:18-32.
54. Liang TJ, Bodenheimer HC Jr, Yankee R, et al. Presence of hepatitis B and C viral genomes in US blood donors as detected by polymerase chain reaction amplification. J Med Virol 1994;42:151-7.
55. Wang JT, Wang TH, Sheu JC, et al. Detection of hepatitis B virus DNA by polymerase chain reaction in plasma of volunteer blood donors negative for hepatitis B surface antigen. J Infect Dis 1991;163:397-9.
56. Liang TJ, Isselbacher KJ, Wands JR. Rapid identification of low level hepatitis B-related viral genome in serum. J Clin Invest 1989;84:1367-71.
57. Baginski I, Chemin I, Hantz O, et al. Transmission of serologically silent hepatitis B virus along with hepatitis C virus in two cases of posttransfusion hepatitis. Transfusion 1992;32:215-20.
58. Blum HE. Hepatitis B virus: significance of naturally occurring mutants. Intervirology 1993;35:40-50.
59. Chazouilleres O, Mamish D, Kim M, et al. Occult hepatitis B virus as source of infection in liver transplant recipients. Lancet 1994;343:142-6.
60. Thiers V, Lunel F, Valla D, et al. Post-transfusional anti-HCV-negative non-A non-B hepatitis (II) serological and polymerase chain reaction analysis for hepatitis C and hepatitis B viruses. J Hepatol 1993;18:34-9.
61. Goodrich RP, Yerram NR, Tay-Goodrich BH, et al. Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives. Proc Natl Acad Sci USA 1994;91:5552-6.
62. Horowitz B, Rywkin S, Margolis-Nunno H, et al. Inactivation of viruses in red cell and platelet concentrates with aluminum phthalocyanine (AIPc) sulfonates. Blood Cells 1992;18:141-50.
63. Margolis-Nunno H, Williams B, Rywkin S, et al. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers. Transfusion 1992;32:541-7.
64. Prodouz KN, Lytle CD, Keville EA, et al. Inhibition by albumin of merocyanine 540-mediated photosensitization of platelets and viruses. Transfusion 1991;31:415-22.
65. Prodouz KN, Lytle CD, Bonner RF, Fratantoni JC. Effects of two viral inactivation methods on platelets: laser-UV radiation and merocyanine 540-mediated photoinactivation. Blood Cells 1992;18:101-16.
66. Wagner SJ, Robinette D, Storry J, et al. Differential sensitivities of viruses in red cell suspensions to methylene blue photosensitization. Transfusion 1994;34:521-6.
67. Leung NW, Tam JS, Lau GT, et al. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases. Cancer 1994;73:1143-8.
68. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994;93:230-9.
69. Pibouin M, Zini R, Nguyen P, et al. Binding of 8-methoxypsoralen to human serum proteins and red blood cells. Br J Dermatol 1987;117:207-15.
70. Lin L, Rheinschmidt M, Metchette K, et al. Storage of platelets in synthetic media: preservation of in vitro platelet function following photochemical decontamination (abstract). Vox Sang 1994;67(Suppl 2):161.
71. Wagner SJ, White R, Wolf L, et al. Determination of residual 4′-aminomethyl-4,5′,8-trimethylpsoralen and mutagenicity testing following psoralen plus UVA treatment of platelet suspensions. Photochem Photobiol 1993;57:819-24.
72. Scott BR. Failure to detect a mutagenic activity of 8-methoxypsoralen (in the dark) in strains of Salmonella typhimurium and Escherichia coli. Mutat Res 1976;40:167-8.
73. McEvoy MT, Stern RS. Psoralens and related compounds in the treatment of psoriasis. Pharmacol Ther 1987;34:75-97.
74. Stern RS, Laird N, Melski J, et al. Cutaneous squamous-cell carcinoma in patients treated with PUVA. N Engl J Med 1984;310:1156-61.
75. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1,380 patients. J Invest Dermatol 1988;91:197-201.
76. Stern RS, Lange R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol 1991;127:347-50.
77. Billard V, Gambus PL, Barr J, et al. Pharmacokinetics of 8-methoxypsoralen (8-MOP) administered intravenously (IV) to humans (abstract). Blood 1993;82(Suppl 1):402a.
78. Stickney J, Billiard V, Gambus P, et al. Pharmacology of 8-methoxypsoralen (8-MOP) after infusion to normal human subjects (abstract). Vox Sang 1994;67(Suppl 2):161.